Dry eyes are also a common source of itch - the result of hormonal changes related to aging, taking certain medications, some autoimmune diseases like rheumatoid arthritis, and staring at screens ...
GSK (GSK) stock is in focus as the company wins FDA nod for Lynavoy, the first U.S. treatment for cholestatic pruritus in ...
The Independent on MSN
Itchy eyes? Experts reveal the causes and how to get relief
Itchy eyes? Experts reveal the causes and what you can do about them - Some 22 million Americans suffer from eye allergies ...
Alfasigma’s buzzer-beater bet on GSK’s rare liver disease prospect has paid off. | Lynavoy is now the first FDA-approved product that can treat cholestatic pruritus in patients with primary biliary ...
The FDA approved linerixibat (Lynavoy) as the first drug indicated for cholestatic pruritus stemming from primary biliary cholangitis (PBC), drugmaker GSK announced on Thursday.
The oral ileal bile acid transporter inhibitor significantly and rapidly reduced cholestatic pruritus in patients with PBC in the phase 3 GLISTEN trial.
Scientists have identified the neurons that worsen the condition during stress. For people with eczema, stress can trigger flare ups and worsen their itchy rashes. But the link between stress and skin ...
Linerixibat targets pruritus pathobiology in PBC by blocking ileal bile acid reuptake, aiming to lower circulating pruritogenic bile acid–related mediators. GLISTEN demonstrated greater 24-week WI-NRS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results